Tidal Investments’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Tidal Investments’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.59M	Sell	76,464 -22,709	-23%	-$756K	﹤0.01%	1227
2026 Q1	$2.99M	Buy	99,173 +24,533	+33%	+$789K	0.01%	1000
2025 Q4	$2.33M	Buy	74,640 +32,380	+77%	+$798K	0.01%	899
2025 Q3	$854K	Buy	+42,260	New	+$742K	﹤0.01%	1295
2024 Q4	–	Sell	-13,856	Closed	-$250K	–	1986
2024 Q3	$250K	Sell	13,856 -28,619	-67%	-$501K	﹤0.01%	1674
2024 Q2	$690K	Buy	+42,475	New	+$654K	0.01%	1102

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Tidal Investments's TEVA Position: Q2 2026 in Review

Tidal Investments reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 23% in Q2 2026, selling an estimated $756K and leaving 76,464 shares worth $2.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1227.

Tidal Investments first reported a position in TEVA in Q2 2024 and has held it in 6 quarters since. The position peaked at $2.99M in Q1 2026. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Tidal Investments held 76,464 shares of Teva Pharmaceutical Industries Limited worth $2.59M as of Q2 2026.
Tidal Investments sold 22,709 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $756K.
Teva Pharmaceutical Industries Limited made up ﹤0.01% of Tidal Investments's portfolio in Q2 2026, its #1227 holding.
Tidal Investments first reported a position in Teva Pharmaceutical Industries Limited in Q2 2024 and has held it in 6 quarters since.
Tidal Investments's Teva Pharmaceutical Industries Limited position peaked at $2.99M in Q1 2026.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.